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Abstract
‘Amelogenesis imperfecta’ (AI) describes a group of inherited diseases of dental enamel that have major clinical impact. Here,
we identify the aetiology driving AI in mice carrying a p.S55I mutation in enamelin; one of the most commonly mutated
proteins underlying AI in humans. Our data indicate that the mutation inhibits the ameloblast secretory pathway leading to
ER stress and an activated unfolded protein response (UPR). Initially, with the support of the UPR acting in pro-survival mode,
Enamp.S55I heterozygous mice secreted structurally normal enamel. However, enamel secreted thereafter was structurally ab-
normal; presumably due to the UPR modulating ameloblast behaviour and function in an attempt to relieve ER stress.
Homozygous mutant mice failed to produce enamel. We also identified a novel heterozygous ENAMp.L31R mutation causing AI
in humans. We hypothesize that ER stress is the aetiological factor in this case of human AI as it shared the characteristic
phenotype described above for the Enamp.S55I mouse. We previously demonstrated that AI in mice carrying the Amelxp.Y64H
mutation is a proteinopathy. The current data indicate that AI in Enamp.S55I mice is also a proteinopathy, and based on com-
parative phenotypic analysis, we suggest that human AI resulting from the ENAMp.L31R mutation is another proteinopathic
disease. Identifying a common aetiology for AI resulting from mutations in two different genes opens the way for developing
pharmaceutical interventions designed to relieve ER stress or modulate the UPR during enamel development to ameliorate
the clinical phenotype.
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Introduction
Mature dental enamel, which is composed of approximately 96%
mineral and 4% organic material and water compared to approxi-
mately 70% mineral and 30% organic material and water found in
dentine and bone, represents the most extreme form of mamma-
lian biomineralization. Enamel mineral is a substituted hydroxy-
apatite (HA) and is the hardest and most resilient of the skeletal
tissues (1). The wear resistance of dental enamel is a conse-
quence of its highly ordered structure; the mineral crystallites are
organized into interlocking prismatic, or rod, structures inter-
spersed with interprismatic crystallites (1,2). Amelogenesis, the
formation of dental enamel, is presumed to be mediated by the
interactions of enamel extracellular matrix proteins coupled with
the regulated deposition of mineral (3). Amelogenesis occurs in
two broad stages and is mediated by a specialized epithelium
comprised of ameloblast cells (3). In the early, secretory stage of
amelogenesis, the ameloblasts elaborate the enamel extracellular
matrix proteins composed principally of amelogenin (>90%),
ameloblastin and enamelin (3). Post-secretory enzymatic process-
ing of the matrix proteins leads to the self-directed organization
of the enamel extracellular matrix and delineates the three-
dimensional structure of the nascent enamel (3). Once the full
thickness of the enamel has been deposited, the ameloblasts
begin to degrade the enamel extracellular organic matrix and
subsequently increase transport of mineral ions into the forming
enamel (3). Removal of the proteinaceous matrix allows the initial
HA crystallites to grow laterally until the full mineral content of
the tissue is achieved (3).
Inherited defects of dental enamel biomineralization, amelo-
genesis imperfecta (AI; MIM PS104500), constitute a common
group of genetic diseases that occur with an incidence as high
as 1:700 live births (4). Affected individuals frequently experi-
ence severe problems with self-esteem due to the appearance
of their teeth as well as pain due to sensitivity and require sub-
stantial and often complex dental care to manage the condition
(5). The critical role played by the proteins of the extracellular
matrix in enamel biomineralization is highlighted by the dis-
covery that many of the genes mutated in AI encode matrix pro-
teins or the enzymes that modify them (6,7). For example,
mutations in the amelogenin (AMELX) gene underlie X-linked
forms of AI (MIM #301200), while mutations in the gene encod-
ing enamelin (ENAM) are associated with both autosomal dom-
inant and autosomal recessive AI phenotypes (MIM #104500 and
#204650) (6,7). The importance of enamelin for normal amelo-
genesis is clear because ENAM mutations are relatively common
in AI probands causing predominantly autosomal dominant,
and more rarely, autosomal recessive AI (8–18). Enamelin is a
186 kDa phosphorylated glycoprotein secreted as a precursor
into the developing enamel extracellular matrix, where it
undergoes a series of proteolytic cleavages (19,20). Its low abun-
dance (1–5% of matrix protein) and localization at the secretory
front of the enamel matrix have led to the suggestion that it is
important for the regulation of mineral growth during the early
stages of enamel formation (21).
Similarly, mutations in the genes encoding matrix metallo-
peptidase 20 (MMP20) and kallikrein related peptidase 4 (KLK4)
result in autosomal recessive hypomaturation AI (MIM #612529
and #204700) (6,7). Recently, mutations in genes encoding other
classes of proteins, distinct from those of the enamel matrix
(e.g. FAM83H, WDR72, DLX3, LAMB3, C4orf26 and SLC24A4), have
also been shown to be associated with AI, underlining the im-
portance of intracellular proteins in enamel biomineralization
(22–27).
Recently, we described a mouse manifesting an AI pheno-
type that was due to a mutation in Amelx (Amelxp.Y64H). We went
on to show that affected animals demonstrated chronic activa-
tion of the unfolded protein response (UPR). AI in these animals
was an example of a proteinopathy giving rise to ER stress, an
activated UPR and ultimately ameloblast cell death (28). To test
the hypothesis that ER stress and UPR-mediated cell death
might be involved in the more frequently observed form of AI
caused by ENAM mutations, and so represent a major aetiolo-
gical mechanism in AI, we have characterized the M100395
mouse model for AI. This mouse harbours a G-T transversion
that changes a polar serine residue to a hydrophobic isoleucine
at position 55 of the translated enamelin peptide sequence
(ENAMp.S55I) (29). Here, we report the detailed characterization
of the Enamp.S55I mouse phenotype and identify a novel hetero-
zygous ENAMp.L31R mutation in human AI. Comparison of the
phenotype of affected enamel of both species strongly suggests
that the underlying pathological mechanism is similar and in-
volves ER stress.
Results
Incisor teeth of Enamp.S55I mice show gross and
histological abnormalities
The enamel of wild-type mouse incisors showed a translucent,
orange-coloured appearance with sharp, chisel-like edges at the
incisal tip (Fig. 1A). Histologically, the secretory stage enamel
organ of the mandibular incisors exhibited ameloblasts with tall
columnar morphology surmounting a thick, well-organized eo-
sinophilic enamel extracellular matrix (Fig. 1B). During the mat-
uration stage of amelogenesis, wild-type ameloblasts reduced
in height and the enamel extracellular matrix was degraded, as
is characteristic of this stage of enamel formation (Fig. 1C).
In Enamp.S55I heterozygous mice, the incisors were covered
by patches of white, opaque, chalky tissue interspersed with
material of similar appearance to that seen in the enamel of
wild-type mice (Fig. 1D). The secretory stage ameloblasts and
secreted enamel matrix were very similar to wild-type animals,
although the ameloblast secretory front appeared less well
organized and the ameloblast cytoplasm accumulated eosino-
philic material compared to wild-type mice (Fig. 1E). From the
late secretory/early maturation stages onwards, large numbers
of ameloblasts appeared to lose contact with the underlying en-
amel extracellular matrix, forming large cyst-like structures
enclosing pale-staining material (Fig. 1F).
Enamp.S55I homozygous mice manifested a more severe
phenotype with incisors exhibiting a relatively smooth white
surface (Fig. 1G). Differentiated ameloblasts were absent in the
secretory stage of amelogenesis; instead, multicellular aggre-
gates were observed below an amorphous eosinophilic matrix
(Fig. 1H). As the maturation stage of amelogenesis commenced,
the disorganized appearance of the ameloblasts persisted al-
though by now much of the space between them was occupied
by matrix-like eosinophilic material (Fig 1I).
Enamp.S55I mice show abnormal expression patterns of
enamel matrix proteins
Immunolabelling of the enamel matrix proteins amelogenin,
ameloblastin and enamelin in sections of wild-type secretory
enamel organ showed a typical distribution, with amelogenin
occupying the whole of the secreted enamel matrix while ame-
loblastin and enamelin were present predominantly at the
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secretory front of the enamel matrix and at the dentino-enamel
junction (Fig. 2A–C). Additionally, as is usually seen in wild-type
secretory ameloblasts, ameloblastin expression was also de-
tected within the ameloblasts in a supranuclear position (Fig.
2B). Ameloblasts of Enamp.S55I heterozygous mice retained ame-
logenin, ameloblastin and enamelin within their cytoplasm,
while the ‘blister-like’ structures formed by these ameloblasts
also exhibited strong immunoreactivity for each protein (Fig.
2D–F). The distribution of enamel matrix proteins was also ab-
normal in mice homozygous for the Enamp.S55I mutation. Here,
the ameloblasts were rounded and often contained all three en-
amel matrix proteins within their cytoplasm (Fig. 2G–I). In the
immediate extracellular space, the distribution of amelogenin
and enamelin were highly disorganized while ameloblastin was
undetectable. The enamel matrix that was present was immu-
noreactive for amelogenin and enamelin (Fig. 2G and I).
Keratin 14 immunolabelling shows abnormalities at the
secretory front in Enamp.S55I heterozygous mice
Using keratin 14 immunolabelling, the terminal web region of
the secretory ameloblasts from which the specialized secretory
structures, the Tomes’ processes, project into the enamel ma-
trix was readily observed in wild-type mice (Supplementary
Material, Fig. S1A). This region and its associated Tomes’
processes were abnormal at the early stages of enamel matrix
secretion in Enamp.S55I heterozygous mice; the terminal web re-
gion appearing more diffuse and the Tomes’ processes more
disorganized than in wild-type animals (Supplementary
Material, Fig. S1B). In the later stages of enamel matrix secre-
tion, ameloblasts in Enamp.S55I heterozygous mice lost contact
with the underlying matrix following retraction of the Tomes’
process (Supplementary Material, Fig. S1C). The ameloblast
phenotype in Enamp.S55I homozygous mice was so severe that it
was impossible to make meaningful comparisons with wild-
type or heterozygous mice.
Ameloblasts in Enamp.S55I mice show ultrastructural
abnormalities
At the ultrastructural level, wild-type secretory stage ameloblasts
exhibited a tall columnar epithelial morphology containing prom-
inent rough endoplasmic reticulum (RER), central Golgi apparatus
and small cytoplasmic vesicles (Fig. 3A). Tomes’ processes
were present apically, interdigitating with the newly formed
enamel matrix (Fig. 3B). In Enamp.S55I heterozygous mice, the
secretory stage ameloblasts also showed a columnar epithelial
morphology, prominent RER, central Golgi apparatus and cyto-
plasmic vesicles (Fig. 3C). However, the vesicles were often consid-
erably larger than those observed in wild-type mice (Fig. 3C).
Figure 1. Gross and histological appearance of the incisor teeth of wild-type, EnamS55I heterozygous and EnamS55I homozygous mice. (A) The teeth of wild-type mice
have a smooth, orange-coloured, translucent appearance with a sharp incisal edge (arrow). (B) Histologically, during the secretory stage of amelogenesis, the enamel
organ is composed of tall, columnar ameloblasts which secrete an eosinophilic matrix. (C) During the early maturation stage of amelogenesis the ameloblasts have
shortened considerably and the matrix has begun to degrade (less intense eosin staining). (D) The teeth of EnamS55I heterozygous mice are largely white with patches
of normal, orange-coloured enamel on their surface. (E) The secretory stage ameloblasts (a) are tall and columnar as in wild-type mice but their cytoplasm is more
deeply eosin-stained. Contact of the ameloblasts with the matrix is more diffuse (arrow) than in their wild-type counterparts and the secreted matrix is considerably
thinner. (F) By the early maturation stage, the ameloblasts have frequently lost contact with the matrix forming large blister-like structures (arrow) which contain
pale-staining material. (G) The teeth of EnamS55I homozygous mice are completely white and devoid of enamel. (H) The ameloblasts have lost their characteristic col-
umnar structure and form eosinophilic multicellular masses. The matrix produced by these cells is disorganized and contains cellular debris (arrows). (I) By the early
maturation stage, the ameloblasts continue to form multicellular aggregates enclosing eosinophilic material (arrows) while the matrix appears thin and disorganized.
a: ameloblasts; m; matrix. Scale bars: (B, C, E, H) 50lm; (I), 100lm; (F), 500 lm.
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Notably, the Tomes’ processes of the ameloblasts of Enamp.S55I
heterozygous mice were disorganized, crowded and exhibited
a spindle-like appearance compared to those of wild-type mice
(Fig. 3D). Eventually, the Enamp.S55I heterozygous ameloblasts
lost contact with the enamel matrix as the secretory stage of
amelogenesis progressed and formed cyst-like structures
containing electron translucent material (Fig. 3E). Electron dense,
matrix-like material was often seen between these ameloblasts
(Fig. 3E).
The pre-secretory stage ameloblasts of Enamp.S55I homozy-
gous mice initially assumed a columnar morphology but failed
to develop a Tomes’ process (Fig. 3F). Instead, these cells lost
their columnar morphology, adopted an ovoid/spherical ap-
pearance and formed irregular cellular masses (Fig. 3G). These
cells were frequently vacuolated (Fig. 3G) and the cytoplasm
filled progressively with large vesicular structures containing
electron translucent to electron dense material consistent with
the retention of enamel matrix proteins (Fig. 3H). Eventually,
the abnormal ameloblasts degenerated, leaving much cellular
debris and deposits of enamel matrix-like material (Fig. 3I).
Enamel architecture of Enamp.S55I mice is abnormal and
disorganized
Scanning electron microscopy (SEM) of unerupted wild-type in-
cisors showed the typical decussating arrangement of enamel
prisms interspersed with aprismatic material that is character-
istic of rodent incisor enamel (Fig. 4A). In contrast, unerupted
mandibular incisor enamel from Enamp.S55I heterozygous mice
was divided into two architecturally-distinct regions (Fig. 4B).
The inner region, corresponding to tissue initially secreted by
the ameloblasts, comprised decussating enamel prisms similar
to wild-type enamel. In contrast, an outer region, corresponding
to enamel that had been secreted by the ameloblasts at a later
time, consisted of material in which the normal decussating
prism architecture was highly disturbed. This disturbed outer
enamel layer was present in newly erupted tissue (Fig. 4C) but
was quickly lost, presumably due to masticatory wear (Fig. 4D).
In contrast, the apparently normal inner layer of prismatic en-
amel, corresponding to that initially secreted by ameloblasts,
was more resilient, and survived to some extent in the oral en-
vironment. (Fig. 4D). Mandibular incisors from Enamp.S55I homo-
zygous mice failed to exhibit any obvious enamel layer in either
unerupted or erupted tissue (Fig. 4E and F, respectively).
We noted the striking similarity between the enamel pheno-
type of unerupted Enamp.S55I heterozygous mice (Fig. 4B) and the
phenotype of incisor enamel from female mice heterozygous for
the Amelxp.Y64H mutation that we reported previously (Fig. 4G).
Enamel mineral quality and quantity is compromised in
Enamp.S55I mice
Micro X-ray computed tomography (mCT) scans of wild-type
and Enamp.S55I mandibular incisors were taken through sagittal
and transverse planes and calibrated to show quantitative
mineral density (Fig. 5). As expected, wild-type incisors were
characterized by a covering of enamel on the labial aspect of the
incisor (Fig. 5A) that became X-ray opaque as the maturation
stage of amelogenesis advanced and enamel mineral density
increased. The enamel density continued to increase following
eruption due to the presence of mineral ions in the saliva (post-
eruptive maturation). The molar teeth, which do not continually
develop, and are therefore present in their completed form, can
also be seen, exhibiting typical fully mature erupted enamel.
Figure 2. Enamel matrix protein distribution in EnamS55I mutant mice. (A–C) Wild-type mice. (A) Strong amelogenin immunoreactivity in the extracellular matrix of
wild-type mice. (B) Ameloblastin immunoreactivity can be seen within the ameloblasts and at the secretory front (yellow arrows) of the matrix and extending as paral-
lel lines into it. There is non-specific immunolabelling of the vasculature below the ameloblasts (white arrows). (C) Enamelin shows strong immunoreactivity at the
dentino-enamel junction (yellow arrows) and at the secretory front (white arrows) with less intense immunostaining throughout the remainder of the matrix. (D–F)
EnamS55I heterozygous mice. (D) In EnamS55I heterozygous mice there is strong amelogenin immunoreactivity in the matrix and within the ameloblasts. (E) Little immu-
noreactivity is observed in the matrix of heterozygous mice but there is strong intracellular immunolabelling for ameloblastin in the ameloblasts. (F) Strong enamelin
immunoreactivity is seen throughout the matrix and within the ameloblasts. (G–I) EnamS55I homozygous mice. (G) There is intense amelogenin immunoreactivity both
in the matrix and within the ameloblasts. (H) Strong ameloblastin immunolabelling is confined to the ameloblasts. (I) There is strong enamelin immunoreactivity
within the ameloblasts and weaker immunostaining of the matrix. a: ameloblasts; m; matrix. Scale bars: 50 lm.
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Incisors from Enamp.S55I heterozygous mice differed from
wild-type in that the developing enamel matrix became X-ray
opaque more anteriorly, indicating a delay in the onset of
maturation stage secondary mineralization (Fig. 5B). Thereafter,
enamel mineralization was irregular. However, on eruption,
the enamel appeared to undergo considerable post-eruptive
mineralization such that the surviving enamel was more
uniformly mineralized and to a higher density (arrowed) than
the unerupted tissue. In some cases, the boundary between the
structurally normal enamel and the abnormal outer enamel
described previously was visible as a hypomineralized region
(Supplementary Material, Fig. S2). Mature molars from
Enamp.S55I heterozygous mice also appeared to be mineralized,
though we are unable to attribute this to post-eruptive mineral-
ization as these teeth were already fully developed and erupted
in these animals.
In contrast to the Enamp.S55I heterozygous mice, incisors and
molars from Enamp.S55I homozygotes were devoid of any X-ray
opaque tissue where enamel would normally be present (Fig. 5C).
An animated supplemental video is provided online show-
ing rendered reconstructions of mandibles from heterozygous
Enamp.S55I and wild-type mice. This video further illustrates the
structural and compositional defects in both erupted and uner-
upted incisor enamel associated with the Enamp.S55I mutation.
Enamp.S55I ameloblasts show evidence of endoplasmic
reticulum stress
Expression of mutant proteins can lead to the retention and ac-
cumulation of misfolded protein intermediates within the
endoplasmic reticulum (ER), triggering the UPR (30). Increased
expression of the ER luminal chaperone HSPA5 (GRP-78, BiP) is
central to this process as the cell attempts to restore the protein
folding capacity of the ER. Immunohistochemical detection of
HSPA5 in wild-type incisors (Fig. 6A) revealed moderate immu-
noreactivity within the secretory ameloblasts consistent with
their strong protein synthetic activity during this stage of ame-
logenesis. By contrast, in secretory ameloblasts of Enamp.S55I
homozygous mice, HSPA5 immunofluorescence was substan-
tially greater than that seen in wild-type animals (Fig. 6B).
Quantitative RT-PCR (RTqPCR) analysis of cDNA derived from
micro-dissected, secretory-stage ameloblasts of wild-type and
Enamp.S55I mice for Hspa5 gene expression levels showed statis-
tically significant upregulation in both heterozygous (P¼ 0.0286)
and homozygous (P¼ 0.0429) mice compared to wild-type
(Fig. 6C).
Ddit3 (Chop) encodes a protein involved in triggering apop-
totic cell death during periods of prolonged ER stress. RTqPCR
analysis of cDNA from the secretory ameloblasts of Enamp.S55I
Figure 3. Ultrastructure of EnamS55I ameloblasts. (A, B) Wild-type secretory stage ameloblasts (A) display a tall columnar morphology with abundant, peripherally
organized rough endoplasmic reticulum (black arrows) surrounding a centrally placed Golgi apparatus and associated small vesicles (white arrows). (B) At the amelo-
blast tip is a specialized secretory structure, the Tomes’ process (T) that secretes enamel matrix in such a manner that the matrix that is deposited from the tip gives
rise to enamel prisms (P) while that derived from its flanks produces inter-prismatic (IP) enamel. Adjacent Tomes’ processes, sectioned more transversely, can also be
seen and these secrete their enamel matrix in a different orientation, (t), to give rise to the interlocking arrangement of enamel prisms. (C–E) EnamS55I heterozygous
mice the secretory ameloblasts also have (C) abundant rough endoplasmic reticulum (black arrows) but also contain larger intracellular vesicles of varying electron
translucency (white arrows) when compared to wild-type. Extracellular accumulation of matrix-like material is also seen just under the secretory front of the amelo-
blasts (white asterisks). (D) The Tomes’ processes of these ameloblasts are abnormal (T) appearing disorganized, crowded and slim. (E) As the maturation stage of ame-
logenesis is approached, the ameloblasts (a) of EnamS55I heterozygous mice retract their Tomes’ processes and lose contact with the enamel matrix and form cyst-like
structures (black asterisk) containing matrix-like material. (F–I) The secretory stage ameloblasts of EnamS55I homozygous mice are initially columnar (F) with accumula-
tions of matrix-like material between them (white arrows). (G) Later in the secretory stage of amelogenesis, EnamS55I homozygous ameloblasts lose their columnar
morphology and become ovoid or spherical. Many of the cells contain large vacuoles (black arrows). (H) At higher magnification the ameloblasts of EnamS55I homozy-
gous mice contain prominent rough endoplasmic reticulum (black arrows). Large vesicles containing material of strong to weak electron translucency (black asterisks)
as well as vacuolar structures (white arrows) are often seen in these ameloblasts. (I) At later stages of amelogenesis, homozygous ameloblasts show extensive vacuol-
ation (black arrows) and accumulations of matrix like material appear around and between them (white arrows). Scale bars: (A, B, C, D), 2 lm; (E, F, G), (I) 5 lm; (H) 1 lm.
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heterozygous mice showed that Ddit3 expression was not sig-
nificantly different to wild-type whereas expression in
Enamp.S55I homozygous mice was increased significantly com-
pared to both wild-type (P¼ 0.0286) and Enamp.S55I heterozygous
(P¼ 0.0429) mice (Fig. 6C).
Ameloblasts in Enamp.S55I homozygous mice show
increased apoptosis but not proliferation
Apoptosis is a normal feature of amelogenesis with approxi-
mately 50% of the ameloblast population being culled during
the transition and maturation stages.
Immunohistochemistry using an antibody to activated
caspase-3, a key effector of apoptosis, in incisors from Enamp.S55I
heterozygous mice revealed occasional ameloblasts with cyto-
plasmic immunoreactivity towards the end of the secretory
stage of amelogenesis (Fig. 6D), an appearance that is indistin-
guishable from wild-type mice (data not shown). Activated
caspase-3 immunolabelling of incisors from Enamp.S55I homozy-
gotes showed large numbers of caspase-3-positive presumably
apoptotic ameloblasts, in the multicellular masses that arise at
the secretory stage in these mice (Fig. 6E).
Caspase-3 is also associated with cellular processes outside
apoptosis such as proliferation (31). To test whether or not the
abnormal caspase-3 distribution detected in the ameloblasts of
Enamp.S55I homozygous mice was associated with dysregulated
ameloblast proliferation, we used antibodies to phospho-
histone H3 to identify any abnormal cell proliferation in the se-
cretory stage enamel organ distal to the proliferative base of the
incisor. Immunolabelling for keratin 14 was also carried out in
these preparations to discriminate cells of the enamel organ
from those of the surrounding connective tissue. No enamel
organ cells distal to the proliferative base were immunoreactive
with the phospho-histone H3 antibody in any of the specimens
examined (Fig. 6F and G) although some cells were immunola-
belled in the surrounding connective tissue (e.g. Fig. 6F) in
EnamS55I heterozygous mice. At the apices of the mandibular in-
cisors, where new ameloblasts are continuously generated from
a stem cell pool, phosphohistone H3 positive cells were
observed in all mice examined (data not shown).
A novel ENAMp.L31R mutation causes AI in humans
We identified a white British family segregating autosomal
dominant hypoplastic AI (Fig. 7A and B). Whole exome sequenc-
ing (WES) of individual III:2 was performed and a heterozygous
variant in enamelin (ENAM; OMIM *606585), c.92T>G, p.(L31R)
(NM_031889.2; NP_114095.2) identified. Sanger sequencing con-
firmed the variant and demonstrated that it segregated with the
disease phenotype in all available members of the family (Fig.
Figure 4. SEM comparing the structure of wild-type, heterozygous and homozygous EnamS55I and female heterozygous AmelxY64H mandibular incisor enamel.
(A) Transverse sections through a wild-type incisor at eruption show the well organized, decussating pattern of enamel prisms characteristic of rodent incisor enamel.
Only the very outermost layer of enamel is aprismatic. (B) In contrast, heterozygous EnamS55I enamel exhibits a structurally normal decussating inner layer of enamel
topped with a subsequently secreted layer that is structurally abnormal. A dotted white line marks the boundary between the two layers. (C) Sagittal sections through
heterozygous EnamS55I enamel at the point of eruption show that a structurally abnormal outer enamel layer is present. (D) Later, in post-eruptive enamel nearer the
incisal biting edge, the abnormal layer has been lost and only the inner structurally normal enamel layer survives. (E) Homozygous EnamS55I mice fail to secrete any
tissue with structural resemblance to normal enamel (unerupted transverse section). (F) Post-eruptive homozygous EnampS55I incisors exhibit no enamel layer; just a
thin layer of material of unknown composition. (G) The phenotype of heterozygous AmelxpY64H mouse enamel (39) is remarkably similar to that of heterozygous
EnampS55I mice; both exhibiting a structurally normal inner layer and an abnormal outer layer.
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7C). The c.92T>G p.L31R variant is predicted to be pathogenic
by a variety of mutation pathogenicity prediction software
(Supplementary Material, Table S1) and was absent from publi-
cally available databases of variation, including dbSNP146 (32),
Exome Variant Server (http://evs.gs.washington.edu/EVS/) and
Exome Aggregation Consortium (v0.3; http://exac.broadinsti
tute.org/). WES and Sanger sequencing of DNA from an add-
itional four white British families segregating autosomal dom-
inant hypoplastic AI showed that the same variant was present
in all four families and segregated with the disease phenotype
in all cases (Supplementary Material, Fig. S3). Investigation of
orthologous protein sequences (Fig. 7D) found that the L31 resi-
due is conserved in all species analysed and resides within a
conserved hydrophobic region within the ENAM signal peptide.
Enamel architecture associated with ENAMp.L31R in
human AI is abnormal
SEM of a primary incisor from an individual heterozygous for an
ENAMp.L31R mutation showed the presence of a structurally nor-
mal inner layer of enamel, around 50 mm in thickness, with a
clearly demarcated structurally abnormal outer layer of varying
thickness (Fig. 8). The presence of a normal inner enamel layer
and an abnormal outer layer is strikingly similar to the pheno-
type observed in Enamp.S55I mice (Fig. 4). Enamel present on the
upper crown exhibited a layer of enamel that was in general
structurally normal in appearance though at 50–100 mm in thick-
ness considerably thinner than enamel on an unaffected con-
trol primary incisor. We hypothesize that an abnormal enamel
layer was present on the upper crown but since this area of the
tooth would have experienced the greatest amount of attrition
in the mouth the abnormal layer has been lost leaving behind
the structurally normal inner layer that survives in the mouth.
Discussion
Dominant mutations in the ENAM gene are frequently associ-
ated with AI in humans (8,10–18). Our results are consistent
with this observation as both heterozygous and homozygous
Enamp.S55I mice manifest a disturbed enamel phenotype. The
murine data also support observations in human examples of
ENAM-linked AI where the disease-causing allele shows a dos-
age effect (9,16). The validity of the mouse model is further rein-
forced by the remarkable similarity between the heterozygous
Enamp.S55I mouse enamel phenotype and the phenotype ex-
hibited in the case of human AI presented here caused by a het-
erozygous ENAMp.L31R mutation (Figs. 4 and 8).
One aim of the current work was to test the hypothesis that
AI in Enamp.S55I mice is a proteinopathic disease driven by ER
stress and an activated UPR that affects ameloblast function ul-
timately leading to ameloblast apoptosis. In addition, we
wished to test the hypothesis that proteinopathy may be a fac-
tor in human AI. However, it is not feasible to study amelogene-
sis in humans at the molecular level; instead our approach was
to study exfoliated human teeth and compare the enamel
phenotype to phenotypes observed in well-characterized mouse
AI models where we believe the phenotype is diagnostic for the
disease aetiology. To this end, we have identified a case of
human AI linked to an ENAMp.L31R mutation for which exfoliated
teeth were available for study.
Proteinopathies are generally related to the misfolding of
proteins in the secretory pathway. Misfolding may be due to a
mutation in the protein itself or to compromised function of an-
cillary proteins (e.g. chaperones, kinases etc.) responsible for
Figure 5. Calibrated micro X-ray computed tomography comparing mineral density in wild-type, heterozygous and homozygous EnamS55I enamel. (A) Sagittal CT sec-
tions show that wild-type incisor enamel becomes X-ray opaque due to increased mineral density (secondary mineralization) that occurs at the beginning of the mat-
uration stage. Mineral density increases gradually throughout maturation and following eruption. Transverse CT sections, taken at points indicated by the dotted
lines, show the enamel layer is complete across the width of the labial aspect of the incisor. (B) In contrast, onset of secondary mineralization is delayed in heterozy-
gous EnamS55I enamel (asterisk) and only approaches the density seen in wild-type mice following eruption. Transverse sections show that secondary mineralization is
compromised across the whole width of the enamel. (C) Homozygous EnamS55I do not exhibit any X-ray opaque material corresponding to incisor enamel. Only wild-
type and heterozygous EnamS55I mice exhibit molar enamel (A and B). The molar teeth of all mice are fully erupted in these mice and no developing enamel is present.
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folding, post-translational modification and trafficking of the
nascent translation product (33). Misfolded proteins, exhibiting
inappropriate protein-protein interactions and aggregation in
the secretory pathway, are increasingly recognized as being re-
sponsible for a wide range of ‘conformational’ diseases includ-
ing, Alzheimer’s disease, Huntington’s disease, atherosclerosis,
cystic fibrosis and type 2 diabetes (34,35). When misfolded pro-
teins accumulate, membrane sensors (IRE1a, PERK and ATF6) in
the ER membrane trigger the UPR in an attempt to relieve ER
stress and restore homeostasis (36). The UPR is a complex
homeostatic network of signalling pathways that has a varied
range of effects on cell function depending on the precise na-
ture of the challenge. The initial UPR response to ER stress at-
tempts to relieve the stress via multiple mechanisms, including
reducing the general secretory load, increasing the volume of
the ER, and upregulating the synthesis of chaperones such as
HSPA5 to increase rescue of protein misfolding. In addition, the
UPR can directly modulate a number of metabolic processes
such as energy metabolism and lipid synthesis. The signalling
outputs of the UPR are graded and mirror the intensity of the ER
stress (37) but ultimately, if homeostasis cannot be restored, the
UPR switches from pro-survival mode into a pro-apoptotic
mode including upregulation of pro-apoptotic transcription fac-
tors such as DDIT3/CHOP (38).
We previously showed that ameloblasts of mice carrying
the Amelxp.Y64H mutation retained amelogenin in multiple intra-
cellular vesicles triggering persistent ER stress that eventually
induced cell death mediated via the UPR (39). In the current
investigation, we have observed a very similar aetiology in
Enamp.S55I mice. In Enamp.S55I mice, the ordered relationship be-
tween the ameloblast monolayer and the enamel matrix being
secreted is disturbed, enamel protein secretion is impaired, ER
stress is increased, and the UPR is activated.
The similarities between Amelxp.Y64H and Enamp.S55I mouse
enamel extend to the characteristic structural enamel pheno-
type observed, suggesting that this phenotype may be charac-
teristic for AI where ER stress is involved. Mice heterozygous for
both Amelxp.Y64H and Enamp.S55I secrete an initial layer of enamel
that appears structurally normal in terms of its prismatic struc-
ture but enamel secreted subsequently is structurally abnormal
and disorganized in both genotypes (Fig. 4B and G). This abnor-
mal outer layer is quickly lost following eruption, presumably
by attrition, while the structurally ‘normal’ inner enamel layer
survives to some extent suggesting retention of functionality
(compare Fig. 4C and D). The reason why the abnormal outer
layer is lost on tooth eruption may be related to a
hypomineralized boundary seen using mCT between the two
distinct layers (Supplementary Material, Fig. S2) representing a
‘fault line’ susceptible to the shear forces encountered during
mastication.
Clearly, any proposed aetiological mechanism operating in
the Enamp.S55I heterozygous mice needs to account for the en-
amel phenotype described above. The fact that approximately
50 mm of structurally normal enamel is secreted initially indi-
cates that Enamp.S55I translation products have little or no im-
pact on the ability of ameloblasts to produce the characteristic
Figure 6. Analysis of cell death, proliferation and ER stress in EnamS55I mutant mice. (A, B) Immunolabelling for the ER chaperone HSPA5 (Grp-78) showed moderate
immunoreactivity in wild-type secretory stage ameloblasts (A) and also in those of EnamS55I heterozygous mice (data not shown). The ameloblasts of EnamS55I homozy-
gous mice (B) showed a substantial increase in HSPA5 immunofluorescence. (C) Quantitative reverse transcriptase PCR analysis of ER stress gene expression in the se-
cretory stage enamel organ. Hspa5 (Grp-78) gene expression was statistically significantly elevated in EnamS55I heterozygous and homozygous mice compared to wild-
type. Ddit3 (Chop) gene expression, was statistically significantly elevated in EnamS55I homozygous mice but not in EnamS55I heterozygous secretory stage enamel organ
compared to wild-type. The data was analysed using the one-sided Mann-Whitney test. (D, E) Immunolabelling for activated caspase 3 in EnamS55I heterozygous amelo-
blasts (D) shows occasional apoptotic ameloblasts at the transition stage of amelogenesis (arrows) as is typically seen in wild-type animals (data not shown). In
EnamS55I homozygous mice, many of the aberrant ameloblasts in the multicellular masses were seen to be undergoing apoptosis (arrows) (E). (F, G) Dual immunolabel-
ling for phosphohistone H3 (green fluorescence), a marker of cell proliferation and keratin 14 (red fluorescence), to discriminate the enamel organ from the surrounding
connective tissue, showed that in all mutant mice studied none of the ameloblast population showed evidence of proliferation. (F) Where proliferation was observed,
this was confined to the surrounding connective tissue fibroblast population (arrows). Scale bars: (A, B, D, E, G), 50 lm; (F), 100 lm.
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decussating enamel prism structure seen in rodents.
Presumably, sufficient wild-type enamelin is produced and se-
creted to fulfil the functional role of enamelin. However, there-
after, ameloblast function is perturbed leading to the
production of structurally abnormal enamel.
Simple eosin staining in the cytoplasm of secretory amelo-
blasts of affected mice (Fig. 1) together with the immunohisto-
chemical detection of intracellular retention of the enamel
extracellular matrix proteins amelogenin, ameloblastin and
enamelin (Fig. 2) indicated an impairment of the ameloblast se-
cretory pathway. TEM data showed that affected ameloblasts
frequently contained large intracellular vesicles consistent with
enamel protein retention (Fig. 3).
ENAM is autosomal in mice and humans and assuming bi-
allelic expression, all of the ameloblasts will be affected by the
Enamp.S55I mutation. However, homozygous mice are more se-
verely affected as both copies of Enam are mutated which effect-
ively doubles the concentration of mutated ENAMp.S55I entering
the ER when compared to heterozygotes. This could increase
the ER stress generated during intracellular trafficking leading
to a more draconian UPR and an apoptotic end point. In support
of this, expression of the pro-apoptotic transcription factor
DDIT3 was significantly increased in enamel organ cells of
Enamp.S55I homozygous mice compared to both wild-type and
heterozygous litter-mates. In contrast, enamel organ cells of
Enamp.S55I heterozygous mice do not appear to suffer increased
rates of apoptosis as expression of Ddit3 was not significantly
different from wild-type (Fig. 6C). Although ameloblasts from
Enamp.S55I heterozygous mice do not suffer increased levels of
Ddit3 expression (apoptosis), the intracellular retention of pro-
teins (Figs. 1–3) still causes a significant upregulation of Hspa5
(Fig. 6C) indicative of ER stress and an activated UPR (40). Taken
together, the data suggest that ameloblasts of Enamp.S55I hetero-
zygous mice experience ER stress and an activated UPR. We sug-
gest that the UPR, acting in pro-survival mode, permits these
cells to secrete an initial structurally normal layer of enamel
despite indications that the Tomes’ processes may be thinner
than wild-type (Fig. 3). Presumably, enough wild-type enamelin
from the unaffected allele in each ameloblast is produced to
carry out its normal extracellular function (which itself remains
Figure 7. (Ai and ii) The permanent dentition of III:4 is characterized by a generalized rough hypoplastic AI with superficial exogenous staining. (B) Pedigree of family 1.
Individuals are not necessarily shown in age order. Affected individuals are indicated by shading. DNA was available from labelled individuals. Whole exome sequenc-
ing was carried out using DNA from III:2. Teeth were obtained from III:1 and III:4. (C) Sanger sequencing of ENAM exon 3 confirmed the heterozygous c.92T>G variant
(NM_031889.2), originally identified in III:2 by WES, segregated with the disease phenotype in all available family members. (D) Clustal Omega multiple sequence align-
ment of homologous ENAM protein sequences. The arrow indicates the residue altered by the c.92T>G variant, p.L31R (NM_031889.2; NP_114095.2). The affected resi-
due and the ten residues that flank it to either side are included in the alignment. ENAM sequences used: Mouse, Mus musculus NP_059496.1; Rat Rattus norvegicus
NP_001099471.1; Guinea pig, Cavia porcellus XP_003467585.2; Elephant, Loxodonta africana XP_003414215.1; Rhesus macaque, Macaca mulatta XP_014994062.1; Human,
Homo sapiens NP_114095.2; Gorilla, Gorilla gorilla XP_004038829.1; Chimpanzee, Pan troglodytes XP_526591.1; Cow, Bos taurus XP_605463.4; Sheep Ovis aries XP_004009936.1;
Horse Equus caballus XP_001487944.1; Wild boar, Sus scrofa NP_999406.1; Cat, Felis Catus XP_003985351.1; Dog Canis lupus familiaris XP_539305.3.
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unclear). However, as the ER stress becomes chronic, the UPR
signal output undergoes subtle modification; not signalling a
full-blown apoptotic event, but rather, a less dramatic response
such as further limiting protein translation in an attempt to re-
lieve the ER stress. Even though the UPR does not switch to full
apoptotic mode, the observed phenotype indicates that hetero-
zygous ameloblast function is further compromised at this
point and the ameloblasts lose the ability to produce structur-
ally normal prismatic enamel and instead produce the structur-
ally and functionally abnormal enamel compromising the outer
enamel layer.
We might speculate that whatever impact the UPR is having
on ameloblast function, it may manifest itself phenotypically
via an effect on the Tomes process as the Tomes process is
widely regarded as essential to the production of prismatic
enamel.
mCT scanning showed that the onset of secondary mineral-
ization of the enamel matrix was delayed in Enamp.S55I heterozy-
gous mice compared to wild-type (Fig. 5A and B). Under the
influence of maturation stage secondary mineralization, uner-
upted wild-type enamel gradually increased in mineral density
from a density of around 2.0 g/cm3 to around 2.3 g/cm3 at the
point of eruption. In contrast, the unerupted enamel of
Enamp.S55I heterozygotes was poorly mineralized. Much of
the tissue had a similar density to the underlying dentine
(1.5 g/cm3) with sporadic patches of enamel exhibiting a
higher density nearer to 2.0 g/cm3. We suggest that affected
ameloblasts were so compromised due to the effects of ER stress
and general disorganization that one of their normal matur-
ation stage functions, which is to actively pump mineral ions
into the enamel matrix to drive secondary mineralization (3),
was compromised.
However, the enamel matrix clearly retained the capacity
to mineralize as mineral density increased dramatically post-
eruption when the enamel was exposed to saliva and the
structurally normal inner enamel layer appeared to resist
masticatory wear (Fig. 5B arrowed). In contrast, the outer struc-
turally abnormal outer layer, was quickly lost presumably due
to its inability to withstand masticatory forces (Fig. 4D).
Molars in the Enamp.S55I homozygous mice, like the incisors,
were completely lacking enamel. However, molars in heterozy-
gous mice appeared similar to wild-type molars in terms of
mineral density. We hypothesize that any delay in maturation
stage mineralization, similar to that observed in the heterozy-
gous incisors, would be compensated for by post-eruptive min-
eralization that occurs in mouse molars once they are in
contact with saliva (41).
mCT confirmed that the incisors (and molars) of Enamp.S55I
homozygous mice failed to produce any normal enamel layer
emphasizing the critical role played by enamelin in amelogene-
sis and/or the toxicity ensuing when 100% of the enamelin pro-
duced is mutated.
The effect of the Enamp.S55I mutation on the biochemical
properties of the translated protein and any resulting loss of
function or gain of toxicity is unclear. However, the replacement
of the relatively small polar amino acid serine with the larger
non-polar hydrophobic amino acid isoleucine is likely to be sig-
nificant. The alkyl R group of isoleucine limits the conform-
ational options for the polypeptide chain during folding in the
ER (42). The effect of the point mutation may therefore be to
cause misfolding, increased protein-protein interactions and
subsequent ER stress. S55 is also a potential phosphorylation
target of the kinase Fam20c (43). If S55 is indeed phosphory-
lated, the substitution of serine carrying a charged hydophilic
Figure 8. SEM comparison between human control primary incisor enamel and primary incisor enamel suffering the effects of the heterozygous ENAMpL31R mutation.
(A) Control enamel exhibits the typical prismatic structure with organized prisms spanning the entire enamel thickness. (B, C) In contrast, affected enamel recapitu-
lates the phenotype seen in heterozygous EnampS55I and AmelxpY64H mice in that it exhibits an inner layer of enamel exhibiting ordered prismatic structure overlaid
with an outer enamel layer that is structurally abnormal (the two layers being demarcated by the white dotted line). (D) In some areas, affected enamel appears struc-
turally normal and does not exhibit a structurally abnormal outer layer. However, it is not clear whether these apparently unaffected areas simply represent areas
where the structurally abnormal outer layer has been lost due to wear and tear experienced in the mouth.
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phosphate group for isoleucine would change the biochemical
character of this site even more dramatically.
Although almost impossible to prove without access to af-
fected developing human AI teeth, we believe our data provides
evidence that the novel heterozygous ENAMp.L31R human muta-
tion reported here may also drive ER stress. The heterozygous
human ENAMp.L31R phenotype closely mimics the highly charac-
teristic phenotype seen in heterozygous Enamp.S55I mice where
the enamel layer is bifurcated into a structurally normal inner
layer and a structurally abnormal outer layer. The similar
phenotypes suggest that AI linked to the heterozygous
ENAMp.L31R mutation shares a similar disease mechanism based
on an evolving UPR that perturbs ameloblast function at a spe-
cific time point resulting in a switch from producing structurally
normal enamel to producing structurally abnormal enamel.
Sequence analysis of wild-type ENAM using the Phobius predic-
tion tool (44) places residue L31 in the hydrophobic core region
(H-region comprising residues 25–33) of the 39 residue ENAM
signal sequence. The H-region is a critical component in the tar-
geting of secretory proteins. Once the signal sequence emerges
from the ribosome, the H-region interacts with the signal recog-
nition particle and translation is paused while the complex de-
livered to the ER membrane where the ribosome and nascent
peptide are transferred to the translocon. Translation resumes
and the growing peptide is translocated into the ER lumen.
Once translation is complete the signal sequence is usually
cleaved and the protein is released. Mutations in the H region
can abolish translocation and the correct cleavage of the signal
peptide. In the presence of the L31R mutation Phobius no longer
predicted the presence of a signal peptide. The actual impact of
the ENAMp.L31R mutation on enamelin translocation and secre-
tion needs to be verified experimentally. However, highly rele-
vant to the ENAMp.L31R mutation, is a previously published
report detailing a C18R substitution in the H-region of the signal
sequence in human preproparathyroid hormone. This mutation
still permitted parathyroid hormone to be translocated into the
ER but subsequently the protein became trapped in the ER trig-
gering ER stress and classic UPR induced apoptosis (45).
In summary, our data indicate that cellular stress provoked
by a failure of mutant enamelin to adopt the correct conform-
ation within the ER is an aetiological driver leading to AI in
Enamp.S55I mice. This mutation is therefore another example of
AI as a conformational disease. A number of pharmacological
agents are available to overcome the effects of ER stress acting
in various ways such as increasing folding protein folding cap-
acity or inhibiting apoptosis (46). We have already used one
such compound, 4-phenybutyrate, in Amelxp.Y64H heterozygous
female mice, to rescue the AI phenotype (39). The EnamS55I
mouse therefore will provide a further opportunity for us to test
the efficacy of such compounds as potential treatments for AI
and provide information on the wider applicability of such com-
pounds for treating proteopathic disease in general. Such infor-
mation could have clinical value, since the human case of AI
reported here linked to a mutation in the H-region of the enam-
elin signal sequence may be based on a similar ER stress-linked
aetiology. It is noteworthy that phenylbutyrate reduced the
intracellular accumulation of human preproparathyroid hor-
mone exhibiting the C18R substitution in the H-region of the
signal sequence and protected cells against ER stress linked
apoptosis (45). Pharmacological treatment of AI in the decidu-
ous dentition would require delivering a drug to the developing
foetus in utero. Phenylbutyrate is contraindicated during preg-
nancy but it is licensed for use in neonates and children up to
18 years of age to treat urea cycle disorders where it is given in
large doses to act as a nitrogen scavenger to treat hyperammo-
naemia (by providing an alternative pathway for ammonia se-
cretion) (47). Pharmaceutical intervention based on
phenylbutyrate would therefore only be useful to rescue the
permanent dentition. In addition, the fact that we observed
post eruptive mineralization of affected enamel in Enamp.S55I
heterozygotes suggests that enamel in some forms of AI could
benefit from strategies designed to increase/accelerate post-
eruptive maturation in humans. The ability to use mouse mod-
els to understand AI mechanism in this way coupled with fu-
ture genetic screening will provide clinicians with information
upon which clinical management of their patients’ condition
can be predicated.
Materials and Methods
Animals
The mutant mouse line M100395 (Enamp.S55I) was obtained from
RIKENGSC (http://www.gsc.riken.jp/Mouse/) and maintained on
a C57Bl/6J genetic background. All procedures were performed
in accordance with the UK Animals (Scientific Procedures) Act,
1986.
Human tissue samples
An exfoliated human primary incisor affected by AI linked to an
ENAMp.L31R mutation was collected in the UK with the approval
of the relevant Research Ethics Committee (reference 13/YH/
0028). Unaffected control primary incisors were obtained from
the Skeletal Tissues Research Bank (School of Dentistry,
University of Leeds) and used with ethical approval and patient
consent.
Histological and immunofluorescence analysis of mouse
enamel organ and developing enamel
Mandibles from 2- to 3-month-old heterozygous and homozy-
gous Enamp.S55I mutant and wild-type mice (n¼ 4 in each cat-
egory) were dissected following cervical dislocation and fixed in
4% paraformaldehyde in PBS, pH 7.4, at room temperature for
48 h. Following fixation, the mandibles were decalcified in 0.5 M
EDTA, dehydrated through a graded ethanol series, cleared in
chloroform, embedded as hemi-mandibles in paraffin wax, sec-
tioned and stained with haematoxylin and eosin. Sections
were examined using a DMRB microscope (Leica) with SpotTM
digital camera and associated software (RTKE/SE Diagnostic
Instruments Inc.). Immunofluorescence analysis was performed
on mandibles prepared as above using antibodies raised against
activated caspase 3 (Abcam, Cambridge, UK), amelogenin FL191,
(Santa Cruz Biotechnology, Santa Cruz, CA), ameloblastin (C17,
Santa Cruz Biotechnology, Santa Cruz, CA), enamelin, phospho-
histone H3 (Abcam, Cambridge, UK), keratin 14 (Abcam,
Cambridge, UK) and GRP-78 (Abcam, Cambridge, UK).
Primary antibodies were detected using biotinylated second-
ary antibodies (Vector laboratories) followed by Cy-3-
conjugated streptavidin (Sigma, Poole, UK) or an AlexaFluor488-
conjugated secondary antibody (Abcam, Cambridge, UK) and
the sections were mounted in fluorescence mountant contain-
ing DAPI (Vector laboratories).
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Quantitative reverse transcriptase-PCR of mouse enamel
organ mRNA
For quantitative RT-PCR analysis total RNA was extracted using
the RNeasy kit (Qiagen, Crawley, UK) from micro-dissected se-
cretory-stage enamel organs (4 wild-type male, 4 Enamp.S55I het-
erozygous and 4 Enamp.S55I homozygous mice) and quantified
using a NanoDrop 2000 spectrophotometer (ThermoShandon,
Runcorn, UK), then reverse transcribed to complementary DNA.
Quantitative RT–PCR was performed according to the manufac-
turer’s instructions on a StepOne Plus machine using SYBR
Green master mix (Life Technologies, Paisley, UK) and analysed
using the DD-Ct method, normalized to b-actin (levels of which
were consistent in all samples). Results were analysed using a
one-tailed Mann-Whitney U test. The following primer pairs
were used for the analysis: Hspa5 5’-ATCTTTGGTTGCTTGTCG
CT-3’, 5’- ATGAAGGAGACTGCTGAGGC-3’; Ddit3 5’- GACCAGGT
TCTGCTTTCAGG-3’, 5’- CAGCGACAGAGCCAGAATAA-3’; Actb 5’-
CTAAGGCCAACCGTGAAAAGAT-3’, 5’- GCCTGGATGGCTACGTA
CATG-3’.
Identification of ENAM mutation in human AI
Genomic DNA was obtained from saliva collected using
OrageneVR DNA Sample Collection kits (DNA Genotek, Ottawa,
ON, Canada) as detailed in the manufacturer’s instructions.
Three micrograms of genomic DNA was prepared for
whole-exome sequencing using the SureSelect All Exon v5 XT
reagent (Agilent Technologies, Santa Clara, CA, USA).
Sequencing was performed on an Illumina Hi-Seq 2500
sequencing platform (Illumina, San Diego, CA, USA), using a
100 bp paired-end protocol. Fastq files were aligned to the
human reference genome (GRCh37) using Novoalign software
(Novocraft Technologies, Selangor, Malaysia). The resulting
alignment was processed in the SAM/BAM format using the
SAMtools, Picard (http://picard.sourceforge.net) and GATK
programs to correct alignments around indel sites and mark
potential PCR duplicates (48,49).
Indel and single-nucleotide variants were called in the VCF
format using the Unified Genotyper function of the GATK pro-
gram. Using the dbSNP database at NCBI, any variants present
in dbSNP142 with a minor allele frequency (MAF)1% were then
excluded and the remaining variants were annotated using in-
house software freely available at http://sourceforge.net/pro
jects/vcfhacks/. Variants in genes known to cause AI were
prioritized for investigation.
PCR and sanger sequencing
The variant was confirmed and segregation was tested in all
available family members. Primer sequences can be found in
Supplementary Material, Table S2. PCR mastermix HotShot
Diamond (Clent Life Science, Stourbridge, UK) was used to amp-
lify sequences. Sanger sequencing was performed using the
BigDye Terminator v3.1 kit (Life Technologies, Carlsbad, CA,
USA) according to manufacturer’s instructions and resolved on
an ABI3130xl sequencer (Life Technologies). Results were ana-
lysed using SeqScape v2.5 (Life Technologies).
The ENAM variant identified in this study has been submit-
ted to the Leiden Open Variant Database at http://dna2.leeds.ac.
uk/LOVD/ variant ID: ENAM000018 and ClinVar, accession num-
ber SCV000328938.
Transmission electron microscopy
Two-month-old mouse mandibles (3 wild-type male, 3
Enamp.S55I heterozygous and 3 Enamp.S55I I homozygous mice)
were dissected following cervical dislocation and fixed in 2%
paraformaldehyde/2% glutaraldehyde prepared in 0.1 M cacody-
late buffer containing 0.15 M sucrose and 2 mM calcium chloride
(pH 7.3) at 4 C overnight. Hemi-mandibles were demineralized
as above and dissected axially into posterior, medial and anter-
ior portions. Following dissection, the samples were washed
with cacodylate buffer, post-fixed in 1% osmium tetroxide,
dehydrated through a graded ethanol series, cleared in propyl-
ene oxide and embedded in Epoxy resin (100 resin, Agar
Scientific Ltd, Stanstead, UK)). Ultrathin sections were con-
trasted with uranyl acetate and lead citrate, and examined on a
Philips model 400 transmission electron microscope.
Scanning electron microscopy
Three hemi-mandibles from 2- to 3-month-old heterozygous
and homozygous Enamp.S55I mutant and wild-type mice were
dissected following cervical dislocation and fixed in 4% parafor-
maldehyde in PBS, pH 7.4, at room temperature for 48 h. Erupted
incisors or mandibles were cut transversely with a scalpel and
the cut surfaces polished using1000 grit wet and dry carborun-
dum paper followed by final polishing with 12 000 grit nail file to
obtain transverse sections through either the erupted or uner-
upted incisor enamel. Smear layers were removed by etching
the ground surface in 30% phosphoric acid for 20 s followed by
thorough rinsing in excess de-ionized water. Teeth were dried
overnight under vacuum and sputter coated with gold.
Specimens were observed using a Hitachi S-3400N scanning
electron microscope (in secondary electron imaging mode)
operated at an accelerating voltage of 20 kV and an emission
current of 80 mA.
An exfoliated human primary incisor affected by AI linked to
an ENAMp.L31R mutation was fractured along the buccal-lingual
mid line. The fractured surface was polished, etched, sputter
coated and examined by SEM as described above.
Micro X-ray computed tomography
Three hemi-mandibles from 2- to 3-month-old heterozygous
and homozygous Enamp.S55I mutant and wild-type mice were
dissected and fixed as described for scanning electron micros-
copy followed by mounting in sealed polypropylene micro tubes
(to prevent drying out) together with hydroxyapatite standards.
Micro X-ray computed tomography was carried out using a
Skyscan 1172 CT scanner (Bruker, Kontich, Belgium). Scans were
obtained using a tube voltage of 75 kV at a constant power of 10
W. Image pixel resolution was 8–10 mm and a 0.5 mm alumin-
ium filter was used to reduce beam hardening. The scanner was
used in oversize scan mode which allowed hydroxyapatite
standards to be imaged along with each individual sample for
mineral density calibration purposes. The standards used had
relative densities of 0.25, 0.75 (Bruker, Kontich, Belgium) and 2.9
(Himed, Old Bethpage, USA). Projection images were recon-
structed using Recon software (Bruker, Kontich, Belgium).
Quantitative mineral density maps were generated using
ImageJ software (http://imagej.nih.gov/ij/) and 3D rendered vid-
eos produced using CTVox software (Bruker, Kontich, Belgium).
The exfoliated human AI tooth and a corresponding healthy
control tooth along were scanned as described above except the
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tube voltage was increased to 100kV and the aluminium and
copper filter were engaged to reduce beam hardening.
Supplementary Material
Supplementary Material is available at HMG online.
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